Evidence map›Paper›PMID 33493021›Full record

ArticleJCO global oncology2021

Multisector Collaborations and Global Oncology: The Only Way Forward.

Charmaine Blanchard, Buhle Lubuzo, Frederick Chite Asirwa, Xolisile Dlamini, Susan C Msadabwe-Chikuni, Michael Mwachiro, Cyprien Shyirambere, Deo Ruhangaza, Dan A Milner, Katherine Van Loon and 5 more

Open access · goldAbstract read
In one paragraph

Article in JCO global oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 6 countries.

Charmaine BlanchardUniversity of Witwatersrand, Johannesburg, South Africa.
Buhle LubuzoUniversity of KwaZulu Natal, South Africa.
Frederick Chite AsirwaInternational Cancer Institute, Eldoret, Kenya.
Xolisile DlaminiMinistry of Health, Mbabani, Kingdom of Eswatini.
Susan C Msadabwe-ChikuniCancer Diseases Hospital, Lusaka, Zambia.
Michael MwachiroTenwek Hospital, Bomet, Kenya.
Cyprien ShyirambereButaro District Hospital, Butaro, Rwanda.
Deo RuhangazaButaro District Hospital, Butaro, Rwanda.
Dan A MilnerAmerican Society for Clinical Pathology, Chicago, IL.
Katherine Van LoonUniversity of California, San Francisco, San Francisco, CA.
Rebecca DeBoerUniversity of California, San Francisco, San Francisco, CA.
Phangisile MtshaliBristol-Myers Squibb Foundation, Johannesburg, ZA.
Ute DuganBristol-Myers Squibb, New York, NY.
Ellen BakerUniversity of Texas, MD Anderson Cancer Center, Houston, TX.
Lawrence N ShulmanUniversity of Pennsylvania, Abramson Cancer Center, Philadelphia, PA.
University of California, San Francisco · USUniversity Teaching Hospital of Butare · RWAmerican Society for Clinical Pathology · USBristol-Myers Squibb (Germany) · DEBristol-Myers Squibb (United States) · USMinistry of Health · SZTenwek Hospital · KEThe University of Texas MD Anderson Cancer Center · USUniversity of KwaZulu-Natal · ZAUniversity of Pennsylvania · USUniversity of the Witwatersrand · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAt the 12th meeting of AORTIC (African Organization for Research and Training in Cancer) in Maputo, Mozambique, held between November 5 and November 8, 2019, a special workshop was organized to focus on the need for collaboration and coordination between governments and health systems in Africa with academic, industry, association, and other nongovernmental organizations to effect sustainable positive change for the care of patients with cancer.

methodsRepresentatives from seven different projects in Africa presented implementation science and demonstration projects of their to date efforts in cancer system improvement including patient access, South-South partnerships, in-country specialized training, palliative care consortium, treatment outcomes, and focused pathology and diagnostic capacity building. Key partners of the various projects served as moderators and commentators during the session.

resultsFrom across all the presentations, lessons learned and exemplary evidence of the value of partnerships were gathered and summarized.

conclusionThe concluding synthesis of the presentations determined that with the broad needs across cancer requiring in-depth expertise at each point on a patient's journey, no single organization can effect change alone. Multipartner collaborations not only should be the norm but should also be coordinated so that efforts are not duplicated and maximum patient access to cancer diagnosis and care is achieved.

Indexed as

Capacity BuildingOrganizationsAfricaHumansMozambique

Identifiers

PMID33493021
PMCPMC8081550
OpenAlexW3121428612

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.